Spots Global Cancer Trial Database for osteopenia
Every month we try and update this database with for osteopenia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast Cancer | NCT00859703 | Breast Cancer Menopause Osteopenia | Risedronate Placebo | 18 Years - | Hospices Civils de Lyon | |
| Do Aromatase Inhibitors (AIs) Decrease Intestinal Calcium Absorption? | NCT00766532 | Breast Cancer Osteoporosis Osteopenia Fracture | Aromatase Inhib... | - | University of Wisconsin, Madison | |
| OsseoScrew Versus Fenestrated Pedicle Screws Augmented With Polymethylmethacrylate | NCT01613144 | Osteoporosis Poor Bone Quali... | OsseoScrew Spin... | 18 Years - | Alphatec Spine, Inc. | |
| Study of Adults With Low Growth Hormone Who Survived Childhood Cancer Where Treatment Caused Low Bone Density | NCT00145704 | Osteopenia | bisphosphonate ... Vitamin D suppl... Calcium | 18 Years - | State University of New York - Upstate Medical University | |
| Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss | NCT00925600 | Cancer Cataract Low Bone Minera... Osteopenia Osteoporosis Prostate Cancer | Denosumab Placebo | 30 Years - 120 Years | Amgen | |
| Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast Cancer | NCT00859703 | Breast Cancer Menopause Osteopenia | Risedronate Placebo | 18 Years - | Hospices Civils de Lyon | |
| Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer. | NCT00171340 | Bone Loss Breast Cancer | Zoledronic acid Letrozole | - | Novartis | |
| Study of Adults With Low Growth Hormone Who Survived Childhood Cancer Where Treatment Caused Low Bone Density | NCT00145704 | Osteopenia | bisphosphonate ... Vitamin D suppl... Calcium | 18 Years - | State University of New York - Upstate Medical University | |
| Evaluation of the Functional/Emotional Life Characteristics of Ongoing EAT in BC Patients With Reduced BMD | NCT05779566 | Breast Cancer Osteopenia | bone densitomet... | 18 Years - 75 Years | Fundación para la Investigación del Hospital Clínico de Valencia | |
| Study of Adults With Low Growth Hormone Who Survived Childhood Cancer Where Treatment Caused Low Bone Density | NCT00145704 | Osteopenia | bisphosphonate ... Vitamin D suppl... Calcium | 18 Years - | State University of New York - Upstate Medical University | |
| Study of Adults With Low Growth Hormone Who Survived Childhood Cancer Where Treatment Caused Low Bone Density | NCT00145704 | Osteopenia | bisphosphonate ... Vitamin D suppl... Calcium | 18 Years - | State University of New York - Upstate Medical University | |
| OsseoScrew Versus Fenestrated Pedicle Screws Augmented With Polymethylmethacrylate | NCT01613144 | Osteoporosis Poor Bone Quali... | OsseoScrew Spin... | 18 Years - | Alphatec Spine, Inc. | |
| FREE Study - Fracture Reduction Evaluation | NCT00211211 | Osteopenia Osteoporosis Multiple Myelom... Bone Neoplasms | Balloon Kyphopl... | 21 Years - | Medtronic Spinal and Biologics | |
| Pilot Study of Secondary Causes of Osteopenia/Osteoporosis in Adults With Breast and Prostate Cancer | NCT01277562 | Breast Cancer Prostate Cancer Osteopenia Osteoporosis | 18 Years - | City of Hope Medical Center | ||
| Pilot Study of Secondary Causes of Osteopenia/Osteoporosis in Adults With Breast and Prostate Cancer | NCT01277562 | Breast Cancer Prostate Cancer Osteopenia Osteoporosis | 18 Years - | City of Hope Medical Center | ||
| Anastrozole Biphosphonate Study in Postmenopausal Women With Hormone-Receptor-Positive Early Breast Cancer | NCT00082277 | Breast Cancer | Anastrozole Risedronate Sod... | 55 Years - | AstraZeneca | |
| Assessment of Bone Mineral Density in People Living With HIV and KSHV Associated Malignancies: A Retrospective Longitudinal Analysis | NCT04742387 | Kaposi Sarcoma KSHV Associated... Primary Effusio... IL-6 Related KS... | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
| Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer. | NCT00171340 | Bone Loss Breast Cancer | Zoledronic acid Letrozole | - | Novartis |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
